Jul 19Chief Business Officer appointed at Accession Therapeutics as company prepares for clinical trials
Nov 29, 2022Accession Therapeutics is attending the J.P. Morgan 41st Annual Healthcare Conference - January 2023
Nov 21, 2022Accession Therapeutics raises £16.6m to advance potent immunotherapies towards clinical trials